SIRT1 plays a critical role in promoting autophagy and modulating NF-κB signaling in both sorafenib-resistant and parental hepatocellular carcinoma cells, highlighting its potential as a therapeutic target in HCC treatment. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.